Cargando…
Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
Eosinophilic esophagitis (EE) is a chronic immune/antigen-mediated esophageal inflammatory disease for which off-label topical corticosteroids (e.g., budesonide) are widely used in clinic. In general, thickening excipients are mixed with industrial products to improve the residence time of the drug...
Autores principales: | Casiraghi, Antonella, Gennari, Chiara Grazia, Musazzi, Umberto Maria, Ortenzi, Marco Aldo, Bordignon, Susanna, Minghetti, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150804/ https://www.ncbi.nlm.nih.gov/pubmed/32121553 http://dx.doi.org/10.3390/pharmaceutics12030211 |
Ejemplares similares
-
Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
por: Casiraghi, Antonella, et al.
Publicado: (2020) -
Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, 12, 211
por: Zur, Eyal
Publicado: (2020) -
Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance
por: Musazzi, Umberto M., et al.
Publicado: (2018) -
Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process
por: Casiraghi, Antonella, et al.
Publicado: (2020) -
A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
por: Warzecha, Joanna, et al.
Publicado: (2022)